CardiacSense Email Format
Medical Equipment ManufacturingHaifa, Israel11-50 Employees
CardiacSense develops a wearable medical device in the form of a smartwatch focused on cardiac monitoring. The device has CE and FDA clearance and is designed to continuously detect atrial fibrillation and other arrhythmias using both photoplethysmography and ECG signals. In addition to rhythm tracking, it measures respiration rate and oxygen saturation to support patients with congestive heart failure and COPD. The company indicates plans for cuff-less absolute blood pressure clearance in the second quarter of 2024, and positions the device as a tool for remote patient monitoring, chronic care management, and telemedicine through sensor-based health data. Based in Haifa, Israel, CardiacSense operates in the medical equipment manufacturing sector with a small to mid-sized team. Its target market includes healthcare providers and patients needing continuous cardiac monitoring and remote health management, offering a solution that integrates with RPM, CCM, and telemedicine workflows. A recent development supporting market reach is a distribution agreement with Bulzi Inc. announced in September 2023 for CardiacSense’s medical-grade watch.